Universal Health (UHS) Reports In-Line Q4 EPS; offers guidance
Universal Health (NYSE: UHS) reported Q4 EPS of $5.88, in-line with the analyst estimate of $5.88. Revenue for the quarter came in at $4.49 billion, versus $4.51 billion reported last year.
GUIDANCE:
Universal Health sees FY2026 EPS of $22.64-$24.52, versus the consensus of $23.39. Universal Health sees FY2026 revenue of $18.417-18.789 billion, versus the consensus of $18.244 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
